Roberts LR - Search Results

1

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.

Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR. Chaiteerakij R, et al. Among authors: roberts ro, roberts lr. Hepatology. 2013 Feb;57(2):648-55. doi: 10.1002/hep.26092. Epub 2012 Dec 12. Hepatology. 2013. PMID: 23055147 Free PMC article.

2

Hepatocytes in the bile duct-ligated rat express Bcl-2.

Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Kurosawa H, et al. Among authors: roberts lr. Am J Physiol. 1997 Jun;272(6 Pt 1):G1587-93. doi: 10.1152/ajpgi.1997.272.6.G1587. Am J Physiol. 1997. PMID: 9227497

3

Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes.

Roberts LR, Kurosawa H, Bronk SF, Fesmier PJ, Agellon LB, Leung WY, Mao F, Gores GJ. Roberts LR, et al. Gastroenterology. 1997 Nov;113(5):1714-26. doi: 10.1053/gast.1997.v113.pm9352877. Gastroenterology. 1997. PMID: 9352877

4

Dysregulation of apoptosis as a mechanism of liver disease: an overview.

Patel T, Roberts LR, Jones BA, Gores GJ. Patel T, et al. Among authors: roberts lr. Semin Liver Dis. 1998;18(2):105-14. doi: 10.1055/s-2007-1007147. Semin Liver Dis. 1998. PMID: 9606808 Review.

5

Cathepsins as effector proteases in hepatocyte apoptosis.

Roberts LR, Adjei PN, Gores GJ. Roberts LR, et al. Cell Biochem Biophys. 1999;30(1):71-88. doi: 10.1007/BF02737885. Cell Biochem Biophys. 1999. PMID: 10099823 Review. No abstract available.

6

Tumor seeding complicating radiofrequency ablation of hepatocellular carcinoma.

Decker GA, Gores GJ, Roberts LR. Decker GA, et al. Among authors: roberts lr. J Hepatol. 2003 May;38(5):692. doi: 10.1016/s0168-8278(03)00028-x. J Hepatol. 2003. PMID: 12713885 No abstract available.

7

A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.

Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. Kipp BR, et al. Among authors: roberts lr. Am J Gastroenterol. 2004 Sep;99(9):1675-81. doi: 10.1111/j.1572-0241.2004.30281.x. Am J Gastroenterol. 2004. PMID: 15330900

8

Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

Roberts LR, Gores GJ. Roberts LR, et al. Semin Liver Dis. 2005;25(2):212-25. doi: 10.1055/s-2005-871200. Semin Liver Dis. 2005. PMID: 15918149 Review.

9

MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE. Baudhuin LM, et al. Among authors: roberts lr. J Cancer Res Clin Oncol. 2006 Mar;132(3):159-62. doi: 10.1007/s00432-005-0056-6. Epub 2005 Nov 15. J Cancer Res Clin Oncol. 2006. PMID: 16292541

10

Emerging drugs for hepatocellular carcinoma.

Roberts LR, Gores GJ. Roberts LR, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):469-87. doi: 10.1517/14728214.11.3.469. Expert Opin Emerg Drugs. 2006. PMID: 16939386 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters